Moneycontrol
HomeNewsVideosBusinessMarketsEmerging opportunities can help re-rate Divi’s lab
Trending Topics
Sensex Today
IT Stocks
Cohance Life Shares
Diamond Power Share Price

Emerging opportunities can help re-rate Divi’s lab

Divi’s Lab is a leading API manufacture of India, primarily known for its market share in molecules like naproxen, gabapentin, and dexamethrophan. While its performance in last few quarters has been impacted due to multiple headwinds, it is well positioned for the new earnings drivers like contrast media and completion of new facility next year

Moneycontrol News
September 01, 2023 / 13:16 IST
Story continues below Advertisement
Remove Ad

Moneycontrol News
TAGS: #Divis Lab #stockoftheday #stocks #video
first published: Sep 1, 2023 01:16 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Follow Us On: Facebook twitter instagram linkedin telegram youtube
Trending Topics
PM Modi Speech Live Ind vs Pak Live Score H1B Visa News Maruti Suzuki Victoris Review H1B Visa Fee Tejashwi Yadav KTR Mithun Manhas Zubeen Garg Asia Cup 2025 Schedule
News
Business Markets Stocks India News City News Economy Mutual Funds Personal Finance IPO News Startups
Markets
Home Currencies Commodities Pre-Market IPO Global Market Bonds
Personal Finance
Home Loans up to 50 Lakhs Credit Cards Lifetime Free Finance Tracker New Fixed Deposits Fixed Deposit Comparison Fixed Income
Mutual Funds
Home MC 30 Top Ranked Funds ETFs Mutual Fund Screener
Tools
Income Tax Calculator EMI Calculator Retirement Planning Gratuity Calculator Petrol Price in India Diesel Price in India IFSC Code
Community
Stock Markets
Network 18 Sites
News18 Firstpost CNBC TV18 News18 Hindi Cricketnext Overdrive
Quick Links
About Us Contact Us Advisory Alert Advertise with Us Disclaimer Privacy Policy Cookie Policy Terms & Conditions Financial Terms (Glossary) Sitemap Investors
Download MC Apps:

Copyright © Network18 Media & Investments Limited. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.